产品编号 :
Cas No. :
CAS No. |
172927-65-0 |
|---|---|
中文名称 |
(E)-2-((1-((4-(N'-羟基脒基)苯甲酰基)-L-丙氨酰基)哌啶-4-基)氧基)乙酸乙酯 |
英文名称 |
ethyl (E)-2-((1-((4-(N'-hydroxycarbamimidoyl)benzoyl)-L-alanyl)piperidin-4-yl)oxy)acetate |
别名 |
Sibrafiban;WBNUCLPUOSXSNJ-UHFFFAOYSA-N;Acetic acid, 2-[[1-[(2S)-2-[[4-[(Z)-amino(hydroxyimino)methyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-, ethyl ester |
标准英文名 |
ethyl (E)-2-((1-((4-(N'-hydroxycarbamimidoyl)benzoyl)-L-alanyl)piperidin-4-yl)oxy)acetate |
分子式 |
C20H28N4O6 |
分子量 |
420.47 |
精确分子量 |
420.20 |
SMILES |
CCOC(=O)COC1CCN(C(=O)[C@H](C)NC(=O)C2=CC=C(/C(N)=N\O)C=C2)CC1 |
标准SMILES |
C[C@H](NC(=O)C1C=CC(=CC=1)/C(/N)=N\O)C(=O)N1CCC(CC1)OCC(=O)OCC |
用途 |
Sibrafiban is a selective glycoprotein IIb/IIIa receptor antagonist that inhibits platelet aggregation; it is used as an orally active, non-peptide, dual prodrug of Ro44-3888 for the prevention of thrombotic events. |
InChIKey |
WBNUCLPUOSXSNJ-ZDUSSCGKSA-N |
|
|
评论 |
|---|